Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 229 results for "mirati"

Mirati Therapeutics To Present Preclinical Data At 2016 American Association For Cancer Research Annual Meeting

Mirati Therapeutics promotes Jamie A. Donadio to CFO

Immuno-oncology company Mirati Therapeutics (NasdaqCM:MRTX) reported on Wednesday that it has appointed Jamie A. Donadio as its senior vice president and chief financial officer with effect from 21 March 2016. Prior to the promotion, Donadio has ... Bloomberg, 1 month ago

Mirati Therapeutics, Inc. Files SEC Form DEF 14A, Other Definitive Proxy Statements (Apr. 19, 2016)

By a News Reporter-Staff News Editor at -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Mirati Therapeutics, Inc. (Form DEF 14A) was posted on April ...
 Equities.com2 days ago DEF 14A - Mirati Therapeutics, Inc. (0001576263) (Filer)  SEC1 week ago MIRATI THERAPEUTICS, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers  Equities.com1 month ago 4 - Mirati Therapeutics, Inc. (0001576263) (Issuer)  SEC Filings1 month ago

BRIEF-Mirati therapeutics- appoints Jamie A. Donadio as CFO

March 23 (Reuters) - * Mirati Therapeutics inc says prior to joining Mirati, donadio was with Amylin pharmaceuticals inc, most recently serving as senior director of finance * Mirati Therapeutics announces promotion of Jamie A. Donadio to ...
 Reuters UK1 month ago

QIAGEN NV : partnersetoodevelop novel compancodediagnosticein lungocanc r var

Collaboration with Mirati Therapeutics targets MET gene mutations to
 4 Traders1 week ago QIAGEN Partners with Mirati Therapeutics, Inc.  Advance for Respiratory Care & Sleep Medicine2 weeks ago QIAGEN Partners to Develop Novel Companion Diagnostic in Lung Cancer  Sys-Con Canada2 weeks ago BRIEF-Qiagen Partners to develop novel companion diagnostic in lung cancer  Reuters UK2 weeks ago
American Banking News - Earnings

Acuta Capital Partners LLC Buys Shares of 88,439 Mirati Therapeutics, Inc. (MRTX)

Acuta Capital Partners LLC bought a new position in shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX) during the fourth quarter, Holdings Channel reports. The institutional investor bought 88,439 shares of the company's stock, valued at ...
 WKRB News1 day ago Mirati Therapeutics, Inc. (NASDAQ:MRTX) Given Average Recommendation of Buy by Analysts  WKRB News1 week ago Ltd. Braslyn Buys 3,400 Shares of Mirati Therapeutics, Inc. (MRTX) Stock  SleekMoney3 weeks ago Ltd. Braslyn Acquires 3,400 Shares of Mirati Therapeutics, Inc. (MRTX) Stock  American Banking News - Forex4 weeks ago

Commit To Buy Mirati Therapeutics At $17.50, Earn 20.7% Annualized Using Options

at 11:42 AM EDT Investors eyeing a purchase of Mirati Therapeutics Inc (MRTX) shares, but cautious about paying the going market price of $21.20/share, might benefit from considering selling puts among the alternative strategies at their disposal.
 Wall Street Select2 days ago

Hodgkin Lymphoma - Pipeline Review, H1 2016

Mirati Therapeutics Inc. Pfizer Inc. Selvita S.A. Summary The report Hodgkin Lymphoma - Pipeline Review, H1 2016, provides an overview of the Hodgkin Lymphoma pipeline landscape. The report provides comprehensive information on the ...
 Research and Markets3 days ago B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2015  Research and Markets3 days ago Global Leiomyosarcoma Pipeline Review, H1 2016 - Research and Markets  4 Traders2 weeks ago New Report Study Leiomyosarcoma Pipeline Review, H1 2016  Empowered News2 weeks ago

QIAGEN geht Partnerschaft zur Entwicklung neuartiger Begleitdiagnostika f¼r Lungenkrebs ein

HILDEN Ziel der Kooperation mit Mirati Therapeutics ist eine Personalisierung der Behandlung durch die Erkennung von Mutationen des MET-Gens QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) hat heute eine Partnerschaft mit Mirati ...
 Bio-Medicine2 weeks ago

Mirati Therapeutics Stock Sees Short Interest Decrease By 14%

The most recent short interest data has been released by the NASDAQ for the 03/31/2016 settlement date, which shows a 254,842 share decrease in total short interest for Mirati Therapeutics Inc (MRTX), to 1,571,517, a decrease of 13.95% since ...
 BioSpace2 weeks ago

Interactive recycled bottle installation demonstrates delicate balance between light and water

At the Paesaggi Mirati art and architecture exhibition, an installation named Tightrope walker, interpreted the festival's social utopia theme as the utopia of balance. Designed and built by Laura Crespi and Corinne Gallotti (a duo of young ...
 EnvironmentGuru.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less